• Catalpol in Diabetes: Pharmacology, Mechanisms, and Preclini

  2026-04-28

  This review synthesizes evidence on Catalpol’s multi-target pharmacological actions against diabetes and its complications, highlighting its modulation of inflammatory and metabolic signaling pathways. The study’s comprehensive pharmacokinetic and safety analysis positions Catalpol as a promising scaffold for anti-diabetic drug development and translational research.

• Carfilzomib (PR-171): Optimizing Proteasome Inhibition Workf

  2026-04-28

  Carfilzomib (PR-171) enables robust, multi-modal cell death induction in cancer models, especially when paired with radiation therapies. This guide delivers advanced protocols, troubleshooting insights, and translational best practices to harness Carfilzomib’s full potential in proteasome inhibition research.

• Gene Expression Profiling Predicts Olaparib Response in MPM

  2026-04-27

  Borchert et al. (2019) demonstrate that specific homologous recombination repair (HRR) gene expression patterns, including BAP1 mutations, predict susceptibility to the PARP inhibitor Olaparib in malignant pleural mesothelioma (MPM). Their findings suggest a subset of MPM patients may benefit from PARP inhibition, especially in combination with cisplatin, guiding future precision oncology strategies.

• Cefodizime (SKU BA1050): Reliable Antibiotic for Lab Assays

  2026-04-27

  This article provides an evidence-based, scenario-driven guide for bench scientists and biomedical researchers evaluating 'Cefodizime' (SKU BA1050) as a third-generation cephalosporin antibiotic for cell viability and resistance assays. It addresses real-world workflow challenges, interprets recent resistance data, and details best-practice parameters—empowering labs to make informed, reproducible choices with APExBIO’s Cefodizime.

• Saquinavir: Advanced HIV Protease Inhibitor Workflows Unlock

  2026-04-26

  Saquinavir, a potent HIV protease inhibitor, empowers high-throughput antiviral and oncology research through robust, reproducible workflows. By integrating cutting-edge permeability modeling and mass spectrometry-based assays, researchers can achieve precise pharmacokinetic profiling and streamlined assay optimization.

• Aztreonam in Advanced Resistance Modeling: Beyond Standard β

  2026-04-25

  Explore the scientific depth of Aztreonam, a monocyclic β-lactam antibiotic, in advanced resistance modeling and metabolic assay design. This article uncovers unique mechanistic insights and protocol recommendations not found in standard guides.

• A-1331852: Advanced BCL-XL Inhibitor Workflows in Cancer Res

  2026-04-24

  A-1331852 enables precise, reproducible inhibition of BCL-XL, overcoming resistance in apoptosis assays and preclinical cancer models. This article delivers practical protocol optimizations, troubleshooting strategies, and translational insights for researchers seeking selective BCL-XL inhibition with data-backed rigor.

• (+)-Bicuculline: Technical Use and Protocol Guide for GABAA

  2026-04-24

  (+)-Bicuculline is a GABAA receptor antagonist used to investigate inhibitory neurotransmission and synaptic signaling in neuroscience research. It is best suited for controlled in vitro and in vivo laboratory studies, especially those examining GABAergic signaling and memory impairment models. Not recommended for diagnostic or clinical use.

• 10074-G5: A c-Myc Inhibitor Transforming Cancer Research Wor

  2026-04-23

  10074-G5 enables high-specificity disruption of c-Myc/Max dimerization, empowering advanced analyses of cell cycle arrest, apoptosis, and tumor regression in cancer models. By integrating quantitative protocols and troubleshooting insights, this guide helps researchers maximize reproducibility and data impact when targeting the oncogenic c-Myc axis.

• Aztreonam in Translational Research: Beyond Resistance Model

  2026-04-23

  Explore how Aztreonam, a monocyclic β-lactam antibiotic, enables advanced Gram-negative research by bridging mechanistic insights with translational assay design. This article uniquely examines its impact on cell models and hepatic metabolism, offering new context for experimental workflows.

• Resveratrol Suppresses EMT in Glioblastoma via Smad Signalin

  2026-04-22

  This article examines a pivotal study demonstrating that resveratrol inhibits epithelial-mesenchymal transition (EMT) and stem cell-like features in glioblastoma (GBM) by modulating Smad-dependent TGF-β signaling. These findings clarify the mechanistic underpinnings of GBM invasiveness and provide experimental evidence supporting TGF-β/Smad pathway targeting in advanced brain tumor research.

• Faropenem Sodium: Next-Gen Strategies in Translational Infec

  2026-04-22

  This article provides a mechanistic and strategic roadmap for translational researchers leveraging Faropenem sodium. It integrates mechanistic transport and cell wall inhibition insights, experimental validation, and best practice protocol guidance. The piece contextualizes Faropenem sodium's unique value in combating antimicrobial resistance while highlighting advanced workflow optimization and the product’s superiority versus conventional antibiotics. It explicitly differentiates itself by connecting mechanistic pharmacokinetics with translational workflow solutions, drawing on both primary literature and current best practices.

• ONX-0914 (PR-957) in Translational Immunoproteasome Research

  2026-04-21

  Explore how ONX-0914 (PR-957) empowers translational researchers to dissect immunoproteasome-mediated mechanisms in autoimmune and inflammatory diseases. This article bridges mechanistic insights, recent peer-reviewed findings, and practical guidance on assay design and cytokine modulation, uniquely positioning ONX-0914 for next-generation immunology research.

• Mitochondrion-Processed TERC: A Noncoding RNA Signal in Cell

  2026-04-21

  This study uncovers a previously unrecognized mitochondrial retrograde signaling mechanism in mammals: the processing of telomerase RNA component (TERC) within mitochondria, its conversion to TERC-53, and the export of this fragment to the cytosol as a regulator of cellular senescence. These findings reveal a telomerase-independent role for TERC-derived noncoding RNA, with broad implications for understanding aging-related pathways and novel epigenetic targets.

• Cytoskeleton Dependence of Mechanical Stress-Induced Autopha

  2026-04-20

  This study demonstrates that microfilaments are essential mediators of autophagy triggered by mechanical compression in human cells, with microtubules playing a supporting role. By dissecting cytoskeletal contributions, the findings clarify mechanotransduction routes relevant to cell survival, stress adaptation, and potential therapeutic targeting.

421 records 18/29 page Previous Next First page 上5页 1617181920 下5页 Last page